Bristol-Myers Squibb

Bristol-Myers Squibb (BMS) is a global biopharmaceutical company with a long-established UK R&D site at Moreton on the Wirral Peninsula and its UK and Ireland commercial headquarters in Uxbridge.

The Moreton facility, expanded in 2025, conducts chemistry, manufacturing and control activities supporting pharmaceutical development and clinical supply.

BMS markets a broad portfolio of approved medicines spanning oncology, cardiovascular disease, immunology, and haematology, and maintains an active pipeline across multiple therapeutic areas.